Zilebesiran (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zilebesiran" in German language version.

refsWebsite

Global rank German rank

2^nd place

3^rd place

2zdb-katalog.de

123^rd place

6^th place

195^th place

255^th place

low place

low place

234^th place

203^rd place

2,769^th place

2,484^th place

1,871^st place

4,217^th place

alnylam.com

Alnylam® Development Pipeline of Investigational RNAi Therapeutics. Abgerufen am 15. Juli 2024 (englisch).

doi.org

Thiago Carvalho: RNA interference treatment targeting angiotensinogen lowers blood pressure. In: Nature Medicine. Band 29, Nr. 12, 16. Oktober 2023, S. 2962–2963, doi:10.1038/d41591-023-00091-x (nature.com [abgerufen am 15. Juli 2024]).
Rida S. Khan, William H. Frishman: Zilebesiran: A Promising Antihypertensive Therapy Inhibiting Angiotensinogen Synthesis. In: Cardiology in Review. ISSN 1061-5377, S. 10.1097/CRD.0000000000000645, doi:10.1097/CRD.0000000000000645 (lww.com [abgerufen am 15. Juli 2024]).
Akshay S. Desai, David J. Webb, Jorg Taubel, Sarah Casey, Yansong Cheng, Gabriel J. Robbie, Don Foster, Stephen A. Huang, Sean Rhyee, Marianne T. Sweetser, George L. Bakris: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. In: New England Journal of Medicine. Band 389, Nr. 3, 20. Juli 2023, ISSN 0028-4793, S. 228–238, doi:10.1056/NEJMoa2208391 (ed.ac.uk [abgerufen am 15. Juli 2024]).

ed.ac.uk

research.ed.ac.uk

Akshay S. Desai, David J. Webb, Jorg Taubel, Sarah Casey, Yansong Cheng, Gabriel J. Robbie, Don Foster, Stephen A. Huang, Sean Rhyee, Marianne T. Sweetser, George L. Bakris: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. In: New England Journal of Medicine. Band 389, Nr. 3, 20. Juli 2023, ISSN 0028-4793, S. 228–238, doi:10.1056/NEJMoa2208391 (ed.ac.uk [abgerufen am 15. Juli 2024]).

lww.com

journals.lww.com

Rida S. Khan, William H. Frishman: Zilebesiran: A Promising Antihypertensive Therapy Inhibiting Angiotensinogen Synthesis. In: Cardiology in Review. ISSN 1061-5377, S. 10.1097/CRD.0000000000000645, doi:10.1097/CRD.0000000000000645 (lww.com [abgerufen am 15. Juli 2024]).

nature.com

Thiago Carvalho: RNA interference treatment targeting angiotensinogen lowers blood pressure. In: Nature Medicine. Band 29, Nr. 12, 16. Oktober 2023, S. 2962–2963, doi:10.1038/d41591-023-00091-x (nature.com [abgerufen am 15. Juli 2024]).

who.int

INN Recommended List 86, World Health Organisation (WHO), 2. September 2021.

zdb-katalog.de

Rida S. Khan, William H. Frishman: Zilebesiran: A Promising Antihypertensive Therapy Inhibiting Angiotensinogen Synthesis. In: Cardiology in Review. ISSN 1061-5377, S. 10.1097/CRD.0000000000000645, doi:10.1097/CRD.0000000000000645 (lww.com [abgerufen am 15. Juli 2024]).
Akshay S. Desai, David J. Webb, Jorg Taubel, Sarah Casey, Yansong Cheng, Gabriel J. Robbie, Don Foster, Stephen A. Huang, Sean Rhyee, Marianne T. Sweetser, George L. Bakris: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. In: New England Journal of Medicine. Band 389, Nr. 3, 20. Juli 2023, ISSN 0028-4793, S. 228–238, doi:10.1056/NEJMoa2208391 (ed.ac.uk [abgerufen am 15. Juli 2024]).